Delivery Order SPE2DB20D3103-SPE2DB24FP8J7

Award Date 8/8/24
Potential Completion Date 8/9/24
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,143.28 Firm Fixed Price delivery order is for "FIRST-MOUTHWASH BLM SUSPENSION 237ML" medical supplies, with a performance period through September 25, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,444.98 firm fixed-price delivery order is for the supply of 4565241277 FIRST-MOUTHWASH BLM SUSPENSION 119ML. The contract has an ultimate completion date of July 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,438.87 firm fixed price delivery order is for the provision of a FIRST-MOUTHWASH BLM SUSPENSION 119ML product. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,717.96 Firm Fixed Price Delivery Order contract is for the delivery of a FIRST-MOUTHWASH BLM SUSPENSION 119ML product. The contract has an ultimate completion date of October 23, 2024 and was awarded on October 22, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,225.88, is a Firm Fixed Price Delivery Order for the procurement of "FIRST-MOUTHWASH BLM SUSPENSION 119ML" medical supplies. The contract has an ultimate completion date of September 20, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,284.35, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FIRST-MOUTHWASH BLM SUSPENSION 119ML, a medical product, with a completion date of January 8, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of FIRST-MOUTHWASH BLM SUSPENSION 119ML. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $5,062.75 and an ultimate completion date of July 31, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued at up to $999,999,999 and $750,000, respectively, to...
This federal contract award is for the delivery of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA). The prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order contract valued at $4,301.08 for the supply of "FIRST-MOUTHWASH BLM SUSPENSION 119ML" medical products. The contract has a May 11, 2023 completion date and is a firm fixed-price, delivery order type contract. No set-aside designation was used...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The $1,689.46 Firm Fixed Price Delivery Order is for the supply of "FIRST-MOUTHWASH BLM SUSPENSION 119ML" medical products. The contract has an ultimate completion date of September 18, 2024. Amerisourcebergen, a major pharmaceutical distributor, is providing these critical medical supplies without any set-aside designation. This award is part of...
This federal contract award, with ID SPE2DB24D1034|SPE2DB24FWAR4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,313.21 firm fixed-price delivery order is for the supply of "FIRST-MOUTHWASH BLM SUSPENSION 119ML", a medical product, with a completion date of June 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FP8J7
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,651.11 firm-fixed-price delivery order is for the supply of "FIRST-MOUTHWASH BLM SUSPENSION 119ML" medical products. The award has an ultimate completion date of August 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, as well as a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation, both of which cover a comprehensive range of pharmaceutical and medical supply products. These IDCs serve as primary vehicles for providing essential medical commodities to support military healthcare programs and other federal beneficiaries. The contract award reviewed was not designated with any set-aside requirements, indicating open competition.

Generated 2/27/25, 10:26 AM